Foresite Capital Management Iv, LLC Kinnate Biopharma Inc. Transaction History
Foresite Capital Management Iv, LLC
- $198 Million
- Q1 2024
A detailed history of Foresite Capital Management Iv, LLC transactions in Kinnate Biopharma Inc. stock. As of the latest transaction made, Foresite Capital Management Iv, LLC holds 9,671,643 shares of KNTE stock, worth $0. This represents 13.0% of its overall portfolio holdings.
Number of Shares
9,671,643
Previous 9,671,643
-0.0%
Holding current value
$0
Previous $22.9 Million
12.24%
% of portfolio
13.0%
Previous 11.58%
Shares
1 transactions
Others Institutions Holding KNTE
# of Institutions
63Shares Held
32.9MCall Options Held
94.7KPut Options Held
802K-
Orbimed Advisors LLC San Diego, CA8.01MShares$00.48% of portfolio
-
Foresite Capital Management V, LLC Larkspur, CA3.53MShares$015.38% of portfolio
-
Viking Global Investors LP1.82MShares$00.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.08MShares$00.0% of portfolio
-
Deltec Asset Management LLC1.04MShares$00.56% of portfolio
About Kinnate Biopharma Inc.
- Ticker KNTE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 44,145,600
- Description
- Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; ...